866039-42-1 Usage
Description
(2,5-DICHLORO-4-PYRIDINYL)METHANOL is a chemical compound characterized by the presence of a 2,5-dichloropyridine moiety attached to a hydroxymethyl group. It is a versatile chemical reagent with potential applications in the synthesis of various pharmaceutical agents.
Uses
Used in Pharmaceutical Industry:
(2,5-DICHLORO-4-PYRIDINYL)METHANOL is used as a chemical reagent for the preparation of CB2 agonists, which are compounds that selectively activate the CB2 receptor. These agonists have potential therapeutic applications in treating various conditions, including pain, inflammation, and neurodegenerative disorders.
(2,5-DICHLORO-4-PYRIDINYL)METHANOL is also used as a chemical reagent in the preparation of benzoquinazolinone derivatives. These derivatives act as M1 receptor positive allosteric modulators, which can enhance the activity of the M1 receptor. The M1 receptor is involved in various physiological processes, including cognition, memory, and muscle contraction. Modulating the activity of the M1 receptor may have potential therapeutic benefits in treating cognitive disorders and other conditions related to M1 receptor function.
Check Digit Verification of cas no
The CAS Registry Mumber 866039-42-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,0,3 and 9 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 866039-42:
(8*8)+(7*6)+(6*6)+(5*0)+(4*3)+(3*9)+(2*4)+(1*2)=191
191 % 10 = 1
So 866039-42-1 is a valid CAS Registry Number.
866039-42-1Relevant articles and documents
BICYCLIC PROLINE COMPOUNDS
-
Paragraph 0348-0351, (2018/02/22)
The invention is concerned with the compounds of formula (I) and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
-
Paragraph 0276, (2017/08/01)
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as a medicament such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the attached DESCRIPTION.
